Study of TQB3454 for advanced solid tumors with IDH1 gene changes
Part of Cancer clinical trials.
This study tests an experimental drug called TQB3454 in people with advanced solid tumors, including brain tumors (gliomas) and bile duct cancer. The drug targets a specific gene change (IDH1) that may help control tumor growth. Participation may offer a new treatment option when standard treatments have stopped working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have an advanced solid tumor (like glioma or bile duct cancer) that has not responded to standard treatment or for which no standard treatment exists.
- You are willing to provide a tumor tissue sample (from a previous surgery or biopsy) for testing.
- Your blood counts and liver/kidney function are within acceptable levels (no recent blood transfusions or growth factors).
- You are able to take oral medication and swallow tablets.
- You agree to use effective contraception during the study and for 6 months after (if applicable).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called QLS5133 for people with advanced solid tumors (cancers that have spread). The drug may help shrink tumors or slow their growth. The study is in two phases to find the right dose and see how well it works.
This trial tests a new tablet, TQB3455, for people with certain blood cancers (MDS or AML) that have an IDH2 mutation. The goal is to see if the drug can help when other treatments haven't worked or aren't possible.
This trial tests an experimental drug called TQB3205 for people with advanced solid tumors that have not responded to other treatments. The study will check if the drug is safe and how it affects the tumors.
This trial tests a new drug, TQB6411, for people with advanced cancers that have not responded to standard treatments. It aims to see if the drug is safe and effective for different tumor types.
This study tests an experimental pill called TQB3217 for people with advanced solid tumors that haven't responded to usual treatments. The goal is to see if the pill is safe, how it works in the body, and whether it helps shrink or slow the cancer.
This study tests a new injection called TQB2930 designed to treat advanced solid cancers (cancers that have spread) that have HER2 protein on their surface. The goal is to see if this treatment can shrink these tumors and help patients live longer.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.